Welsh, Carson, Anderson & Stowe and Healthcare Industry Veteran Announce Formation of U.S. Anesthesia Partners, Inc.

A proactive approach to Cell Line Development: Three challenges driving the push for proactivity

January 1, 1970

Global demand for therapeutics remains high. Keeping up with this need calls for innovation, and many companies are turning to biologics for the answer, with 55 biologics approved in 2021 alone.¹In this second part of the proactive approach to Cell Line Development (CLD) series, we explore three key challenges facing biologics developers and manufacturers driving the growing need. 1. The increasin

Welsh, Carson, Anderson & Stowe and Healthcare Industry Veteran Announce Formation of U.S. Anesthesia Partners, Inc.

A proactive approach to Cell Line Development: Three challenges driving the push for proactivity

U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe Announce Partnership with Greater Houston Anesthesiology